Clinical Trial Update: Sildenafil in HFpEF (Heart Failure With Preserved Ejection Fraction) and PH [Phase 3]

View source ↗

Summary

Phase 3 trial of sildenafil for heart failure with preserved ejection fraction and pulmonary hypertension has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction
• Pulmonary Hypertension

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Heart Failure, Diastolic, Pulmonary Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2016-03-21